首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備呼吸器

市場調查報告書

商品編碼

1458079

全球智慧吸入器市場規模、佔有率、成長分析、依類型（乾粉吸入器和計量吸入器）、依配銷通路、依最終用途 - 2024-2031 年行業預測

Global Smart Inhalers Market Size, Share, Growth Analysis, By Type(Dry powdered inhalers and metered dose inhalers ), By Distribution Channel, By End-Use - Industry Forecast 2024-2031

出版日期: 2024年03月27日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球智慧吸入器市場規模為122.2億美元，預計將從2023年的146.4億美元成長到2031年的621.1億美元，在預測期內（2024-2031年）複合年成長率為19.8%。

快速擴張的全球智慧吸入器市場（醫療保健領域的一個部門）正在徹底改變包括氣喘和慢性阻塞性肺病在內的呼吸系統疾病的治療。智慧吸入器是一種使用感測器和藍牙技術追蹤和監控患者吸入器使用的醫療設備。醫療保健專業人員可以使用智慧吸入器收集的資料來更好地監測患者對處方時間表的遵守情況，並根據需要修改治療策略。透過允許醫療保健從業人員監測患者藥物使用情況並即時調整治療計劃，該行業旨在提高呼吸系統疾病治療的功效和效率。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Teva Pharmaceuticals (Israel)
GlaxoSmithKline (UK)
Novartis (Switzerland)
AstraZeneca (UK)
Boehringer Ingelheim (Germany)
Philips Respironics (US)
Propeller Health (US)
Vectura Group (UK)
Opko Health (US)
Adherium Limited (New Zealand)
AptarGroup (US)
Cohero Health (US)
H&T Presspart (UK)
3M Company (US)
Cipla (India)
Mundipharma (UK)
Glenmark Pharmaceuticals (India)
Chiesi Farmaceutici (Italy)
Propeller Health (US)
Sensirion AG (Switzerland)

簡介目錄

Product Code: SQMIG35A2315

Global Smart Inhalers Market size was valued at USD 12.22 billion in 2022 and is poised to grow from USD 14.64 billion in 2023 to USD 62.11 billion by 2031, growing at a CAGR of 19.8% during the forecast period (2024-2031).

The treatment of respiratory conditions including asthma and COPD is being revolutionized by the quickly expanding global smart inhalers market, a sector of the healthcare sector. Smart inhalers are medical devices that track and monitor patients' inhaler usage using sensors and Bluetooth technology. Healthcare professionals can use the data that smart inhalers collect to better monitor patient adherence to prescription schedules and modify treatment strategies as necessary. By allowing healthcare practitioners to monitor patient drug usage and make real-time treatment plan adjustments, the industry aims to improve the efficacy and efficiency of respiratory disease therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Inhalers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Inhalers Market Segmental Analysis

Global Smart Inhalers Market is segmented on the basis of type, distribution channel, end-use, and region. By type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By end-use, the market is segmented into hospitals, homecare settings, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Smart Inhalers Market

Innovations in technology are a major factor propelling the market for smart inhalers. The treatment of respiratory disorders has changed dramatically as a result of the introduction of sophisticated sensors, networking choices, and data analytics tools. Personalized treatment and better patient outcomes are made possible by smart inhalers' ability to gather and communicate data in real-time to healthcare practitioners about medicine usage, inhaler technique, and environmental variables. One digital therapeutics startup, Propeller Health, has created a sensor-based smart inhaler platform. The platform is made up of a sensor that fits onto common inhalers and monitors drug intake. The gathered information is transferred to a smartphone app, which gives patients and medical professionals information and alerts.

Restraints in the Global Smart Inhalers Market

The comparatively expensive price of smart inhalers in comparison to traditional inhalers is one of the market's limitations. Smart inhalers are more expensive because of their sophisticated technology and connection features. Their broad adoption may be constrained by their cost, especially in areas with scarce healthcare resources and affordability issues. For instance, the cost of a smart inhaler might vary from $100 to $300, based on the features and brand. Patients with low incomes or no insurance may find this increased expense to be problematic. Because of this, the market growth of smart inhalers may be hampered in some markets where their adoption is delayed.

Market Trends of the Global Smart Inhalers Market

The incorporation of machine learning (ML) and artificial intelligence (AI) algorithms into inhaler technology is a significant trend in the smart inhalers market. Large datasets gathered from smart inhalers can be analyzed by AI and ML approaches, which can also spot trends and offer predictive insights. This makes it possible for medical professionals to anticipate exacerbations, optimize medicine dosage, and customize treatment regimens. For instance, the digital health startup Cohero Health has created a smart inhaler system that uses ML and AI algorithms. In order to give patients and healthcare professionals individualized recommendations and real-time feedback, the system examines inhaler usage trends, environmental data, and patient-specific information. This trend demonstrates how AI and ML can be used to improve patient outcomes and the management of respiratory diseases.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Smart Inhalers Market by Type

Market Overview
Dry powdered inhalers (DPIs) and metered dose inhalers (MDIs)

Global Smart Inhalers Market by Distribution Channel

Market Overview
Hospital pharmacies
retail pharmacies
and online pharmacies

Global Smart Inhalers Market by End-Use

Market Overview
Hospitals
homecare settings
and others

Global Smart Inhalers Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Teva Pharmaceuticals (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Respironics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Propeller Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vectura Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Opko Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adherium Limited (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AptarGroup (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohero Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H&T Presspart (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mundipharma (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glenmark Pharmaceuticals (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chiesi Farmaceutici (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Propeller Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sensirion AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments